Meta-Imputation Balanced (MIB): An Ensemble Approach for Handling Missing Data in Biomedical Machine Learning

Missing data represents a fundamental challenge in machine learning applications, often reducing model performance and reliability. This problem is particularly acute in fields like bioinformatics and clinical machine learning, where datasets are frequently incomplete due to the nature of both data generation and data collection. While numerous imputation methods exist, from simple statistical techniques to advanced deep learning models, no single method consistently performs well across diverse datasets and missingness mechanisms. This paper proposes a novel Meta-Imputation approach that learns to combine the outputs of multiple base imputers to predict missing values more accurately. By training the proposed method called Meta-Imputation Balanced (MIB) on synthetically masked data with known ground truth, the system learns to predict the most suitable imputed value based on the behavior of each method. Our work highlights the potential of ensemble learning in imputation and paves the way for more robust, modular, and interpretable preprocessing pipelines in real-world machine learning systems.

Differentiating Viral and Bacterial Infections: A Machine Learning Model Based on Routine Blood Test Values

The growing threat of antibiotic resistance necessitates accurate differentiation between bacterial and viral infections for proper antibiotic administration. In this study, a Virus vs. Bacteria machine learning model was developed to discern between these infection types using 16 routine blood test results, C-reactive protein levels, biological sex, and age. With a dataset of 44,120 cases from a single medical center, the Virus vs. Bacteria model demonstrated remarkable accuracy of 82.2%, a Brier score of 0.129, and an area under the ROC curve of 0.91, surpassing the performance of traditional CRP decision rule models. The model demonstrates substantially improved accuracy within the CRP range of 10 40 mg/L, an interval in which CRP alone offers limited diagnostic value for distinguishing between bacterial and viral infections. These findings underscore the importance of considering multiple blood parameters for diagnostic decision-making and suggest that the Virus vs. Bacteria model could contribute to the creation of innovative diagnostic tools. Such tools would harness machine learning and relevant biomarkers to support enhanced clinical decision-making in managing infections.

COVID-19 diagnosis by routine blood tests using machine learning

Physicians taking care of patients with coronavirus disease (COVID-19) have described different changes in routine blood parameters. However, these changes, hinder them from performing COVID-19 diagnosis. We constructed a machine learning predictive model for COVID-19 diagnosis. The model was based and cross-validated on the routine blood tests of 5,333 patients with various bacterial and viral infections, and 160 COVID-19-positive patients. We selected operational ROC point at a sensitivity of 81.9% and specificity of 97.9%. The cross-validated area under the curve (AUC) was 0.97. The five most useful routine blood parameters for COVID19 diagnosis according to the feature importance scoring of the XGBoost algorithm were MCHC, eosinophil count, albumin, INR, and prothrombin activity percentage. tSNE visualization showed that the blood parameters of the patients with severe COVID-19 course are more like the parameters of bacterial than viral infection. The reported diagnostic accuracy is at least comparable and probably complementary to RT-PCR and chest CT studies. Patients with fever, cough, myalgia, and other symptoms can now have initial routine blood tests assessed by our diagnostic tool. All patients with a positive COVID-19 prediction would then undergo standard RT-PCR studies to confirm the diagnosis. We believe that our results present a significant contribution to improvements in COVID-19 diagnosis.

Application of machine learning for hematological diagnosis

Quick and accurate medical diagnosis is crucial for the successful treatment of a disease. Using machine learning algorithms, we have built two models to predict a hematologic disease, based on laboratory blood test results. In one predictive model, we used all available blood test parameters and in the other a reduced set, which is usually measured upon patient admittance. Both models produced good results, with a prediction accuracy of 0.88 and 0.86, when considering the list of five most probable diseases, and 0.59 and 0.57, when considering only the most probable disease. Models did not differ significantly from each other, which indicates that a reduced set of parameters contains a relevant fingerprint of a disease, expanding the utility of the model for general practitioner's use and indicating that there is more information in the blood test results than physicians recognize. In the clinical test we showed that the accuracy of our predictive models was on a par with the ability of hematology specialists. Our study is the first to show that a machine learning predictive model based on blood tests alone, can be successfully applied to predict hematologic diseases and could open up unprecedented possibilities in medical diagnosis.